Amelie Margarete Lutz, MD, PhDStanford University2009 Gilman Family Scholar Early Detection of Ovarian Cancer Using Targeted Microbubble-Enhanced Ultrasound The primary objective of Dr. Lutz’s proposal is to validate and refine molecularly targeted microbubble contrast enhanced ultrasound (CEUS) for non-invasive, in-vivo imaging of the ovarian cancer-related angiogenesis. Like other solid tumors, ovarian cancer is critically dependent […]
Read More
Young Min Chung, PhDStanford University Targeting Ovarian Cancer with Combination of Olaparib and Trifluoperazine Dr. Chung is developing innovative therapeutic strategies by combining a clinically used small-molecule drug called trifluoperazine (TFP) and a chemical compound named Olaparib, which is an inhibitor of an enzyme called PARP, to suppress advanced ovarian cancer and to overcome PARP […]
Read More
Erinn Rankin, PhDStanford University2016 Pape Family Pilot Study Award Targeting the hypoxic secretome in omental metastasis Mesothelial cells line the abdominal cavity and play an important role in ovarian cancer metastasis. These mesothelial cells in the presence of ovarian cancer tumors are deprived of oxygen (hypoxic) and, as a result, produce components of the hypoxia […]
Read More